6/24/2019  9:59:59 PM Chg. -0.52 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
53.13USD -0.96% 162,322
Turnover: 8.63 mill.
-Bid Size: - -Ask Size: - 69.03 bill.USD 3.76% -

Business description

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,900 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 93 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.
 

Management board & Supervisory board

CEO
Larry J. Merlo
Management board
Eva C. Boratto, Alan M. Lotvin, C. Daniel Haron, Carol A. DeNale, Colleen M. McIntosh, David A. Falkowski, Derica Rice, J. David Joyner, James D. Clark, John P. Kennedy, Jonathan C. Roberts, Karen S. Lynch, Kevin Hourican, Lisa G. Bisaccia, Michael P. McGuire, Rick M. Jelinek, Thomas M. Moriarty, Thomas S. Moffatt, Troyen Brennan
Supervisory board
David W. Dorman, Alecia A. DeCoudreaux, Anne M. Finucane, C. David Brown II, Edward J. Ludwig, Fernando Aguirre, Jean-Pierre Millon, Larry J. Merlo, Mark T. Bertolini, Mary L. Schapiro, Nancy-Ann M. DeParle, Richard J. Swift, Richard M. Bracken, Roger N. Farah, Tony L. White, William C. Weldon
 

Company data

Name: CVS Health Corporation
Address: One CVS Drive,Woonsocket, RI 02895, USA
Phone: +1-401-765-1500
Fax: -
E-mail: -
Internet: https://cvshealth.com
Industry: Consumer Goods
Sector: Consumer services
Sub sector: -
End of financial year: 12/31
Free Float: 84.30%
IPO date: -

Investor relations

Name: Michael P. McGuire
IR phone: +1-800-201-0938
IR-Fax: -
IR e-mail: investorinfo@cvshealth.com

Main Shareholders

Freefloat
 
84.30%
The Vanguard Group, Inc.
 
8.40%
BlackRock Inc.
 
7.30%